Ol-molog

Global Access Diagnostics (GADx) Formed to Expand Affordable Access to Advanced Rapid Diagnostic Technologies

Retrieved on: 
Wednesday, June 15, 2022
Biotechnology, Health, Science, Other Science, Pharmaceutical, Solution, COVID-19, Bill, Global health, CEO, Global South, Company, Onchocerciasis, Leadership, Research, Gaps, GAD, Schistosomiasis, Access Health CT, GAH, Fever Dream, Vaccine, Management, Ol-molog

Global Access Health (GAH), a social enterprise dedicated to providing affordable medical products for global health, today formally introduced its first portfolio company, Global Access Diagnostics (GADx).

Key Points: 
  • Global Access Health (GAH), a social enterprise dedicated to providing affordable medical products for global health, today formally introduced its first portfolio company, Global Access Diagnostics (GADx).
  • GADx has been created to address gaps in the global provision of diagnostics with a focus on expanding affordable access to quality tests.
  • The Company combines expertise in rapid diagnostics development from Mologic Ltd with low-cost manufacturing and scale-up capability of sister company, Global Access Diagnostics (GAD).
  • Through this transaction, the group acquired Mologic and GAD to harness industry-leading expertise in developing and manufacture of rapid diagnostic technologies.

Lateral Flow Immunoassay (LFIA) Based Rapid Test Global Market Research Report 2022 - ResearchAndMarkets.com

Retrieved on: 
Friday, June 3, 2022
Medical Devices, Infectious Diseases, Hospitals, Health, Medical Supplies, Tick-borne disease, Biomarker, LFIA, Company, Food, Infection, Point-of-care testing, POCT, Siemens, A*STAR, Animal, Hologic, Disease, Becton, Dickinson and Company headquarters, University, Blood, Immunoglobulin G, Serum, Method, Immunoglobulin A, Hospital, Coronavirus, Immunoglobulin M, COVID-19, Harvard University, Thermo Fisher Scientific, Antibody, QIAGEN, Toxicology, Severe acute respiratory syndrome coronavirus 2, BioMérieux, SRL Diagnostics, Abbott Laboratories, Pregnancy, Gertrude Pocte Geddes Willis, Asia-Pacific, POC, Danaher Corporation, Application, Fertility, Bio-Rad Laboratories, Ol-molog, Medical device, Oil, Pharmaceutical industry, Vaccine

The "Lateral Flow Immunoassay (LFIA) Based Rapid Test Global Market Report 2022" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Lateral Flow Immunoassay (LFIA) Based Rapid Test Global Market Report 2022" report has been added to ResearchAndMarkets.com's offering.
  • The lateral flow immunoassay (LFIA) based rapid test market consists of sales of devices and equipment used to run lateral flow immunoassays (LFIA) based rapid test and related services by companies that develop lateral flow immunoassays (LFIA) based rapid test equipment.
  • Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
    6.2.
  • Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
    6.3.

Winners Announced Of MCA Awards 2021 After A Record Year Of Entries

Retrieved on: 
Wednesday, November 10, 2021
Human resource policies, Industry, Private, Metropolitan, COVID-19, Public sector, Secretary of State for Business, Energy and Industrial Strategy, Innovation, IBM, Support, SME, VMIC, Ol-molog, Partner, Excellence, Leadership, Vaccine, Atos, Technology, Rising Star, International, Research, Courtauld Institute of Art, Strategy, MCA, FTSE, Tata Steel, Year, IBM Global Services, Business, Kimble, KPMG, EY, Ministry, Vaccines Manufacturing and Innovation Centre, Shell, BEIS, Simon-Kucher & Partners, PricewaterhouseCoopers, Social value, Consultant, Performance improvement, Human, Compliance, Public, Pharmaceutical industry, Audit

LONDON, Nov. 10, 2021 /PRNewswire/ -- The winners of the MCA Awards for 2021 have been announced at a face-to-face ceremony which took place recently with guests including clients, government officials, national media and leading executives across the private and public sector. Following a record year for the awards with an increase of 72% in entries, consultancy firms of all sizes and their clients were recognised for their award-winning projects and 7 individual winners were selected by the panel of 45 independent judges. The MCA Awards Ceremony, now in its 24th year, brought together the largest ever audience at the event in London, which was hosted by comedian and broadcaster, Sandi Toksvig OBE.

Key Points: 
  • Following a record year for the awards with an increase of 72% in entries, consultancy firms of all sizes and their clients were recognised for their award-winning projects and 7 individual winners were selected by the panel of 45 independent judges.
  • The MCA Awards Ceremony, now in its 24th year, brought together the largest ever audience at the event in London, which was hosted by comedian and broadcaster, Sandi Toksvig OBE.
  • Overall, there were 24 award categories with 14 project awards, 7 individual awards and 3 overall awards with 13 SMEs receiving awards as winners or highly commended across all categories.
  • Many of their achievements are recognised in the annual MCA Awards .

Rover Labs Launches Rover CloudLIS, A Modern Cloud-based Laboratory Information System Designed to Simplify COVID-19 Test Registration, Tracking, and Reporting

Retrieved on: 
Tuesday, August 31, 2021
Rover, Ol-molog, Economic development, COVID, Acquisition, Gaps, Initiative, Collection, Government, BBC, National, Multimedia, COVID-19 testing, Patient, CEO, Bill, Bill & Melinda Gates Foundation, NIH, Workflow, Restatement (Second) of Contracts, LIS, Acceleration, COVID-19, View, Pharmaceutical industry, Motor vehicle

Rover CloudLIS offers diagnostic laboratories and COVID-19 test manufacturers around the world a better way to track and report test results instantly at scale.

Key Points: 
  • Rover CloudLIS offers diagnostic laboratories and COVID-19 test manufacturers around the world a better way to track and report test results instantly at scale.
  • CloudLIS works with both lab-based, point-of-care, and over-the-counter test systems to manage the entire COVID-19 testing workflow.
  • From test kit provisioning through test registration and automatic confidential reporting of results, CloudLIS makes the process seamless for both test administrator and recipient.
  • Rover Labs is strategically partnered with Rover Diagnostics, a spin-out ofColumbia University, which participated in the NIH RADx program in 2020.

Lateral Flow Immunoassay (LFIA) Based Rapid Test Global Market Report 2020-2030 - ResearchAndMarkets.com

Retrieved on: 
Thursday, August 12, 2021
Infectious Diseases, Science, Health, Other Science, Abbott Laboratories, Growth, Bio-Rad Laboratories, CE, HIV, Serum, Blood, Thermo Fisher Scientific, SRL Diagnostics, BioMérieux, COVID, Biomarker, Tick-borne disease, Hologic, CAGR, LFIA, Food, Fertility, Company, Becton, Dickinson and Company headquarters, COVID-19, Immunoglobulin A, Danaher Corporation, Immunoglobulin M, Ol-molog, Coronavirus, POC, Antibody, Animal, Toxicology, POCT, Pregnancy, Gertrude Pocte Geddes Willis, Severe acute respiratory syndrome coronavirus 2, Siemens, Americas, Immunoglobulin G, Infection, QIAGEN, Point-of-care testing, A*STAR, Pharmaceutical industry, Medical device, Vaccine

The "Lateral Flow Immunoassay (LFIA) Based Rapid Test Global Market Report 2020-30: COVID 19 Growth and Change" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Lateral Flow Immunoassay (LFIA) Based Rapid Test Global Market Report 2020-30: COVID 19 Growth and Change" report has been added to ResearchAndMarkets.com's offering.
  • This report focuses on lateral flow immunoassay (LFIA) based rapid test market which is experiencing strong growth.
  • The lateral flow immunoassay (LFIA) based rapid test market consists of sales of devices and equipment used to run lateral flow immunoassays (LFIA) based rapid test and related services by companies that develop lateral flow immunoassays (LFIA) based rapid test equipment.
  • Therefore, the need for point-of-care testing under home care settings is expected to drive the Lateral Flow Immunoassay (LFIA) Based Rapid Test market.